跳至主要内容
临床试验/NCT06774703
NCT06774703尚未招募不适用

Nemaline Myopathy Clinical Research Network (NM-CTRN)

Stanford University6 个研究点 分布在 2 个国家目标入组 50 人开始时间: 2025年1月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
50
试验地点
6
主要终点
Validate the change over 36 months using the Alberta Infant Motor Scale (AIMS) Score

研究概览

简要总结

The goal of this study is to establish a research network to help define the natural disease history and clinical outcome measures for Nemaline Myopathy (NM).

详细描述

The long-term aim of this study is to incorporate these outcome measures into clinical trials for NM therapies. Outcome measures to be assessed will be dependent on the participant's age and functional status. Follow-up visits will be conducted either every 3 or 6 months, dependent on age, for a total of 3 years.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
0 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 0-18 years of age at recruitment
  • Confirmation of Nemaline Myopathy (pathogenic or likely pathogenic mutations in ACTA1 (AD) or NEB (AR)
  • Patient and/or parent or legal guardian must be willing and able to provide informed consent

排除标准

  • Clinically significant medical finding on the physical examination, other than NM, that the Investigator deems unsuitable for participation in and/or completion of the study procedures
  • Any confirmed chronic or acute condition or disease affecting any system(s), which could interfere with the results of the study and/or the compliance with the study procedures. This will be subject to the clinical judgement of the Principal Investigator (PI)
  • Participants of ongoing (interventional) clinical trials that assess the efficacy of potential treatments will be excluded
  • Safety concerns

结局指标

主要结局

Validate the change over 36 months using the Alberta Infant Motor Scale (AIMS) Score

时间窗: 36 months

The AIMS is a standardized tool used to assess a child's gross motor development in four positions: prone, supine, sitting, and standing. Percentile scores are given from 0-100, with higher percentiles representing higher motor function.

Validate the change over 36 months using the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP-INTEND)

时间窗: 36 months

The CHOP-INTEND assesses a child's ability to move their body in a lying down position, supported sitting, and assisted rolling through 16 items.

Validate the change over 36 months using the Hammersmith Infant Neurological Examination Section 2 (HINE-2)

时间窗: 36 months

This is a 37-item measure of infant developmental motor milestones divided into the following categories: neurological examination, developmental milestones and behavioral scale, and state of consciousness. Scores for individual categories will be combined into a composite score.This will be performed in participants aged 0-24months. Scores are interpreted in relation to optimality scores and cut-off scores for the participant's age. Higher scores represented higher function.

Validate the change in 32-item Motor Function Measure (MFM32) Scale Score

时间窗: 36 months

This motor function assessment consists of 32 items organized in three dimensions: standing position and transfers, axial and limb proximal motor function, and limb distal motor function. Total scores are given between 0-100, with 0 indicating severe functional impairment and 100 indicating no functional impairment.

Change in Peabody Developmental Motor Scales (PDMS-3) Scale Score

时间窗: 36 months

This is used to measure various motor abilities in young children. Four types of normative scores are yielded: age equivalents, percentile ranks, subtest scaled scores, and composite index scores. Age equivalents are indexes of relative standing that translate subtest raw scores into motor ages. Percentiles provide the examiner with an index that is easily understood. Subtest scaled scores are based on a distribution having a mean of 10 and a standard deviation of 3. Composite indexes are based on a distribution with a mean of 100 and a standard deviation of 15. Higher scores indicate higher level of function.

Change in ambulation over 36 months as measured by the 10 meter walk (m/s).

时间窗: 36 months

This test measures the time taken for a participant to walk 10 metres as quickly and safely as possible. This will be performed in ambulatory participants aged 2 years and older.

Change in ambulation over 36 months as measured by the 6 Minute Walk Test

时间窗: 36 months

This is a measure of how far a participant can walk along a track in 6 minutes. This will be performed in ambulatory participants aged 5 years and older.

Change in respiratory function over 36 months as measured by spirometry, specifically the supine forced vital capacity (FVC).

时间窗: 36 months

This is a measure (% predicted) of the maximum amount of air that can be forcibly exhaled from your lungs after taking the deepest breath possible. This will be performed in participants aged 5 years and older.

次要结局

  • Change in muscle thickness of lower extremity muscles over 36 months as measured by muscle ultrasound.(Baseline through month 36)
  • Skin Biopsy (optional)(Baseline through month 36)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Carolina Tesi-Rocha

Clinical Professor

Stanford University

研究点 (6)

Loading locations...

相似试验

招募中
不适用
Creation of a Clinical Database for the Study of Phenotypic Variability in Motor Neuron DiseasesAmyotrophic Lateral SclerosisMotor Neuron Disease
NCT06318585Istituto Auxologico Italiano200
招募中
不适用
Natural History Study for Charcot Marie Tooth DiseaseCharcot-Marie-Tooth Disease Type 2ICharcot-Marie-Tooth Disease Type 2JCharcot-Marie-Tooth Disease Type 2ECharcot-Marie-Tooth Disease Type 2GCharcot-Marie-Tooth Disease Type 1CCharcot-Marie-Tooth Disease Type 2RCharcot-Marie-Tooth Disease Type 2O (Diagnosis)Charcot-Marie-Tooth Disease Type 2MCharcot-Marie-Tooth Disease Type 2PCharcot-Marie-Tooth Disease Type 2YCharcot-Marie-Tooth Disease Type 4F (Diagnosis)Charcot-Marie-Tooth Disease Type 4B3Charcot-Marie-Tooth Disease Type 2HCharcot-Marie-Tooth DiseaseCharcot-Marie-ToothCharcot-Marie-Tooth Disease, Type IACharcot-Marie-Tooth Disease Type 2ACharcot-Marie-Tooth Disease Type 2Charcot-Marie-Tooth Disease, Type 2CCharcot-Marie-Tooth Disease Type 2A2BCharcot-Marie-Tooth Disease Type 2B2Charcot-Marie-Tooth Disease Type 2A1Charcot-Marie-Tooth Disease Type 4B1Charcot-Marie-Tooth Disease, Type IBCharcot-Marie-Tooth Disease Type 2B1Charcot-Marie-Tooth Disease Type 2U (Diagnosis)Charcot-Marie-Tooth Disease Type 4ACharcot-Marie-Tooth Disease, Type 4A, Axonal FormCharcot-Marie-Tooth Disease Type 2A2ACharcot-Marie-Tooth Disease Type 2S (Disorder)Charcot-Marie-Tooth Disease and DeafnessCharcot-Marie-Tooth Disease Type 4B2Charcot-Marie-Tooth Disease Type 4HCharcot-Marie-Tooth Disease Type 1FCharcot-Marie-Tooth Disease Type 4CCharcot-Marie-Tooth Disease Type 4ECharcot-Marie-Tooth Disease Type 1DCharcot-Marie-Tooth Disease Type 2Q (Diagnosis)Charcot-Marie-Tooth Disease Type 2A2Charcot-Marie-Tooth Disease Type 2N (Diagnosis)Charcot-Marie-Tooth Disease Type 2B5Charcot-Marie-Tooth Disease Type 2DCharcot-Marie-Tooth Disease Type 4DCharcot-Marie-Tooth Disease Type 2KCharcot-Marie-Tooth Disease Type 2L (Diagnosis)Charcot-Marie-Tooth Disease Type 2TX-Linked Charcot-Marie-Tooth DiseaseHNPPCharcot Marie Tooth Disease (CMT)
NCT05902351Hereditary Neuropathy Foundation10,000
招募中
不适用
Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement DisordersNeurodegenerative DiseasesMSA - Multiple System AtrophyAtaxiaSynucleinopathiessca3
NCT05486806Brigham and Women's Hospital50
已完成
不适用
Diagnosis and Natural History Study of Patients With Neurological ConditionsMovement DisorderDementiaParkinson's DiseaseAlzheimer's DiseaseMultiple System Atrophy
NCT00001549National Institute of Neurological Disorders and Stroke (NINDS)600
尚未招募
不适用
Development of a Multidisciplinary Network for Clinical and Laboratory Research for SMASpinal Muscular Atrophy
NCT05866939Fondazione Policlinico Universitario Agostino Gemelli IRCCS400